Levomilnacipran

CAS 96847-54-0 2 FDA-DMF suppliersSmall Molecule

Overview

Levomilnacipran is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL99946).

API suppliers (3)

Suppliers of Levomilnacipran backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.

  • PIERRE FABRE MEDICAMENTFrance1 active DMF
  • PIERRE FABRE MEDICAMENTFrance1 active DMF
  • MSN PHARMACHEM PRIVATE LTD

Patent & exclusivity (US)

Per the FDA Orange Book (8 approved US products), the latest listed US patent on Levomilnacipran expires 22 May 2032 and exclusivity 24 Mar 2026. Generic API sourcing typically opens up once these lapse.

Chemical identity

IUPAC name
cis-(1S,2R)-2-(aminomethyl)-N,N-diethyl-1-phenylcyclopropane-1-carboxamide
Canonical SMILES
CCN(CC)C(=O)[C@]1(C[C@H]1CN)C2=CC=CC=C2
InChIKey
GJJFMKBJSRMPLA-DZGCQCFKSA-N

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.

Start free trialBook a demo